Future Vision
Future Vision is a Shanghai-based pediatric eye care provider, founded in 2015, offering myopia prevention and control, amblyopia rehabilitation training, and medical optometry to children aged 3-16 in China through a clinic-based services model.
- Company typePrivate
- Founded2015
- HeadquartersShanghai, China
- Headcount251–500
- GTM typeB2C
- OfferingServices
Future Vision firmographics
Firmographics- Name
- Future Vision
- Website
- https://wleye.com
- Company type
- Private
- Founded year
- 2015
- Headcount range
- 251–500 employees
- Short description
- Future Vision is a Shanghai-based pediatric eye care provider, founded in 2015, offering myopia prevention and control, amblyopia rehabilitation training, and medical optometry to children aged 3-16 in China through a clinic-based services model.
- Ownership category
- akta.pro rank
Future Vision industry classification
Industry- Product category
- Pediatric Ophthalmology and Optometry Services
- NAICS
- Offices of Optometrists (62132)
- SIC
- Ophthalmic Goods (3851)
- akta.pro primary industry
- Contact Lens Specialty & Myopia Control (HLAKAKAK)
- akta.pro secondary industries
- Low Vision Rehabilitation (HLAKAKAJ), Pediatric Ophthalmology & Orthoptics Devices (Amblyopia Therapy, Strabismus Measurement & Treatment) (HLAHAJAM)
Keywords
Where Future Vision is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Markets served
Future Vision business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Future Vision product offering
Product offeringCore offering
Future Vision provides myopia prevention and control services, amblyopia (lazy eye) rehabilitation training, and medical optometry examinations. The company's services are targeted at children aged 3-16, addressing refractive errors, visual development disorders, and preventative eye health through clinical assessments and vision therapy programs.
Differentiator
Problem solved
Functional benefit
Products and services
- Myopia Prevention and Control
- Amblyopia Rehabilitation Training
- Medical Optometry
Companies that use Future Vision
Customer profileIdeal customer profiles1 record
Future Vision technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Future Vision competitors and assessment
Company assessmentEmerging players
- CooperVision (MiSight): Global contact lens manufacturer whose MiSight 1 day is the first FDA-approved myopia control lens. Comparable as a player addressing the same pediatric myopia control market Future Vision serves, though through a device/lens rather than clinical-service model.
- Euclid Systems Corporation: US-based orthokeratology (ortho-k) lens company serving the myopia control market. Comparable as a specialist player in the pediatric myopia management space, operating in an adjacent geography.
Regional players
- Lucid Korea (now Bausch + Lomb Korea): Korea-based ortho-k and pediatric myopia management specialist. Comparable in product/category focus on pediatric myopia control, though operating primarily in the Korean market.
Broad incumbents
- EssilorLuxottica (Stellest): Global eyewear and lens giant whose Stellest spectacle lens targets myopia control in children. Comparable in addressing the pediatric myopia management category, though via lens products distributed through optical retail rather than clinical services.
- Beijing Tongren Hospital (Pediatric Ophthalmology): Tier-3 public hospital widely regarded as China's leading pediatric ophthalmology center. Comparable as the dominant clinical reference point for pediatric myopia and amblyopia treatment in the same patient market Future Vision addresses.
- Huaxia Eye Hospital Group: Major private eye-hospital chain in China. Directly comparable as a multi-clinic ophthalmology services operator targeting similar patient populations, including pediatric vision.
- C-Mer Eye Care Holdings: Hong Kong-listed Chinese eye-care hospital and clinic operator. Comparable as a multi-site private ophthalmology provider in Greater China, competing for the same pediatric and general eye-care demand.
- Aier Eye Hospital Group: China's largest listed ophthalmology hospital chain. Comparable as a Chinese private eye-care operator serving pediatric and adult patients, though materially larger and broader in scope than Future Vision's pediatric-focused clinics.
- Bausch + Lomb: Global ophthalmic company offering contact lenses and myopia management programs (including acquisition of ortho-k players). Comparable as an incumbent addressing pediatric myopia control, though across a much broader ophthalmic portfolio.
Direct peers
- Eyebright (Tongren-affiliated optometry): China-based optometry and myopia control service brand closely linked to the ophthalmology sector. Directly comparable as a domestic pediatric myopia control and vision-training service competitor.
Market position
Customer concentration
Future Vision financial estimates
Financial estimateRevenue estimate
Valuation estimate
Future Vision leadership team
Management profileNumber of profiles
Future Vision funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Future Vision M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Future Vision
What does Future Vision do?
Future Vision provides myopia prevention and control services, amblyopia (lazy eye) rehabilitation training, and medical optometry examinations. The company's services are targeted at children aged 3-16, addressing refractive errors, visual development disorders, and preventative eye health through clinical assessments and vision therapy programs.
When was Future Vision founded?
Future Vision was founded in 2015. It employs 251 to 500 people.
Where is Future Vision based?
Future Vision is headquartered in Shanghai, China, in the Asia region.
Who are Future Vision's main competitors?
Emerging players on record are CooperVision (MiSight) and Euclid Systems Corporation. Lucid Korea (now Bausch + Lomb Korea) is listed as a regional player. Broad incumbents are EssilorLuxottica (Stellest), Beijing Tongren Hospital (Pediatric Ophthalmology), Huaxia Eye Hospital Group, C-Mer Eye Care Holdings, Aier Eye Hospital Group and Bausch + Lomb. Eyebright (Tongren-affiliated optometry) is listed as a direct peer.
Does Future Vision have an API?
No public API is recorded for Future Vision.
What industry is Future Vision in?
Future Vision's product category is Pediatric Ophthalmology and Optometry Services. Its primary akta.pro industry code is HLAKAKAK, Contact Lens Specialty & Myopia Control, with a secondary code of HLAKAKAJ, Low Vision Rehabilitation. Its NAICS code is 62132 and its SIC code is 3851.